Friday, December 04, 2015 7:29:53 PM
I guess the easiest way to answer that is referring to another post answering a concern about their split history:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118466368
In 2011 Transdel filed for a petition for reorganization under chapter 11 in Bankruptcy court. This timeline coincides with when Mark Baum was brought on as CEO; also 2011. Baum saw the company through the restructuring that year and they requested the court to dismiss the chapter 11 in November 2011. In Feb 2012, they changed their name to Imprimis.
I believe the company than seized the opportunity of compounding pharma on the passing of the Drug Quality and Security Act of 2013 which was put in place to employ strict guidance and oversight in the compounding pharmacy industry.
Not sure if you've read it but here's a link:
http://www.fda.gov/drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM